What did Abbott pay for Exact Sciences?

Abbott acquired Exact Sciences for $21.00B in 2025 (44.2x EBITDA), equivalent to 6.40x revenue. Target revenue was approximately $3275.0M. Target EBITDA was approximately $475.0M.

What does Exact Sciences do?

Exact Sciences is a laboratory services business.

What multiple did Abbott pay for Exact Sciences?

44.2x EBITDA and 6.40x revenue, based on disclosed deal value of $21.00B and disclosed financials.

M&A TRANSACTION · 2025

Exact Sciences acquired by Abbott

$21.00B· 44.2x EBITDA· 6.40x revenue

Target

Exact Sciences

Acquirer

Abbott

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$3275.0M

EBITDA

$475.0M

Deal Value

$21.00B

EV/EBITDA

44.2x

Context

This $21.00B acquisition of Exact Sciences by Abbott sits in the laboratory services sub-vertical. The 44.2x EBITDA multiple paid in 2025 can be compared against the population median for laboratory services transactions of similar size on our Laboratory Services valuation hub. Abbott is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own laboratory services

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Exact Sciences acquisition.

Citation: ExitValue.ai. (2025). Exact Sciences acquired by Abbott. https://exitvalue.ai/deals/exact-sciences-acquired-by-abbott-fairness-opi